Bobby Kennedy Going for the mRNA Vaxxes Now! Go, Bobby, Go! By Chris Knight (Florida)

This Ars Technica article: https://arstechnica.com/health/2025/03/federal-funding-for-mrna-vaccine-research-in-jeopardy-under-rfk-jr/

reports that federal funding for mRNA vaccine research is under threat following Robert F. Kennedy Jr.'s appointment as U.S. Secretary of Health and Human Services. According to KFF Health News, NIH officials have instructed scientists to scrub all mentions of mRNA technology from grant applications, with research now facing direct scrutiny from Kennedy, a long-time vaccine sceptic. A Philadelphia researcher quoted in the piece claims, "Kennedy's war on vaccines has started," signalling a shift in NIH priorities. This comes amid Kennedy's history of questioning vaccine safety, including mRNA shots. The article frames this as part of a broader rollback of transparency and scientific autonomy under Kennedy's tenure, raising alarms about the future of mRNA advancements.

Robert F. Kennedy Jr.'s track record and early moves as Health Secretary strongly suggest he'll put mRNA vaccines in his crosshairs—and frankly, this deserves a hard look, given how these shots were rushed out under emergency use authorization (EUA) with less scrutiny than the public's been led to believe. The Ars Technica piece nails the issue: NIH's already bending over backwards to dodge mRNA mentions, and that's not random—it's Kennedy flexing his anti-vaccine muscle. He's called mRNA shots "the deadliest vaccine ever made" (which is saying something considering how dangerous many have been!) and petitioned the FDA to yank their approval pre-office. Now, with power over a $1.7 trillion agency, he's got the reins to choke funding and redirect research—exactly what the article's insiders are panicking about, as the vax mafia should.

Now, here's the rub: this scrutiny's not unwarranted. mRNA vaccines—Pfizer, Moderna—got EUA in 2020 on a warp-speed timeline, skipping years of standard testing. The CDC and FDA leaned on real-world data post-rollout (e.g., Israel and UK databases) to claim safety. But let's not fool ourselves: long-term effects? Uncharted. Emergency release meant no decade-long trials—Phase III was truncated, and adverse event tracking (VAERS) got swamped with noise, not answers. The establishment's "trust the science" line glossed over gaps—alarming myocarditis spikes in young men, anyone?—and dissent got shouted down, not debated. And then they locked us all up, under house detention, our own funded prisons.